J
Jonathan L. Bramson
Researcher at McMaster University
Publications - 182
Citations - 8060
Jonathan L. Bramson is an academic researcher from McMaster University. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 48, co-authored 170 publications receiving 7264 citations. Previous affiliations of Jonathan L. Bramson include Jewish General Hospital & McMaster-Carr.
Papers
More filters
Journal ArticleDOI
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models
TL;DR: The simplest (single equation) models for tumor growth and greater immunological detail are considered and the necessity for expanding the complexity of models in order to capture the biological mechanisms the authors wish to understand is clarified.
Journal ArticleDOI
Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12
Jonathan L. Bramson,Mary Hitt,Christina L. Addison,William J. Muller,J Gauldie,Frank L. Graham +5 more
TL;DR: AdmIL-12.1 can be used to deliver very high levels of localized cytokine production and it is confirmed that the IL-12 produced from this vector actually affects the local cytokine environment of the tumor and activates responder cells present within the tumor.
Journal ArticleDOI
TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection
Anna Zganiacz,Michael Santosuosso,Jun Wang,Tony T. Yang,Lihao Chen,Maria Anzulovic,Scott Alexander,Brigitte Gicquel,Yonghong Wan,Jonathan L. Bramson,Mark D. Inman,Zhou Xing +11 more
TL;DR: TNF-alpha is identified as a type 1 immunoregulatory cytokine whose primary role, different from those of other type 1 cytokines, is to keep an otherwise detrimental type 1 immune response in check.
Journal ArticleDOI
Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Chris P. Verschoor,Jennie Johnstone,Jamie Millar,Michael G. Dorrington,Mojtaba Habibagahi,Alina Lelic,Mark Loeb,Jonathan L. Bramson,Dawn M. E. Bowdish +8 more
TL;DR: This analysis is the first to demonstrate that MDSCs and specifically the CD11b(+)CD15(+) MDSC subset are increased with age, and this age‐related elevation in the frequency of M DSCs may contribute to the increased cancer incidence that occurs with age.
Journal Article
IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.
Marc J. Greenberger,S L Kunkel,Robert M. Strieter,N. W. Lukacs,Jonathan L. Bramson,J Gauldie,Frank L. Graham,Mary Hitt,J M Danforth,Theodore J. Standiford +9 more
TL;DR: Ex vivo transfection with Ad5mIL-12 resulted in 45% long term survival in Klebsiella pneumonia, whereas no animals with Klebsialla pneumonia receiving control adenovirus survived, and treatment with anti-IFN-gamma Abs or soluble TNF receptor:Ig construct partially and completely attenuated survival benefits observed in animals receiving Ad5MIL- 12, respectively.